ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharma gets USFDA approval for generic chronic constipation treatment tablets
Alembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of one and two milligrams. These tablets are indicated for treating chronic idiopathic constipation in adults. The a
Announcement as on 28 July 2026

Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gel
Alembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval, for the 5% strength, means the company can now market its version, which is therapeutically equivalent to Almirall's
Announcement as on 29 June 2026

Alembic Pharma gets tentative nod from USFDA for generic cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step for the company in the cancer treatment drug market. The approval is for the 45mg strength, with potential for marketin
Announcement as on 19 June 2026

Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This d
Announcement as on 22 May 2026

Alembic Pharma gets USFDA tentative nod for generic prostate cancer drug
Alembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate cancer treatment. The approval is for the 300 mg strength. The drug is a generic version of Nubeqa Tablets. The robust
Announcement as on 14 May 2026

Announcements by Alembic Ltd. first page | Next page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 101.47
  • 12Day Average: 97.31
  • 20Day Average: 92.96
  • 50Day Average: 91.1
  • 100Day Average: 90.4
  • 150Day Average: 89.6
  • 200Day Average: 92.05

506235 Indicators & signals

Indicator MACD (12,26,9)

98.3, 94.43, 2.36
Indicator MACD is in positive zone

Indicator ADX (14)

70.04, 45.16, 7.96
Indicator ADX is indicating that momentum is still strong.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 69
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
03 Thu Sep 2026 109.45 101.34 to 117.91 9.4% 21.3 times
02 Wed Sep 2026 100.05 97.92 to 100.94 1.22% 0.54 times
01 Tue Sep 2026 98.84 97.00 to 101.60 -0.01% 0.76 times
31 Mon Aug 2026 98.85 97.01 to 102.00 -1.3% 1.3 times
28 Fri Aug 2026 100.15 99.62 to 102.97 -2.4% 0.61 times
27 Thu Aug 2026 102.61 97.91 to 104.38 4% 1.98 times
26 Wed Aug 2026 98.66 92.36 to 99.47 4.21% 1.22 times
25 Tue Aug 2026 94.67 90.90 to 96.93 3.34% 1.84 times
24 Mon Aug 2026 91.61 91.19 to 93.93 -1.21% 0.31 times
21 Fri Aug 2026 92.73 90.60 to 93.19 1.42% 0.62 times
20 Thu Aug 2026 91.43 87.25 to 92.50 3.05% 0.82 times
19 Wed Aug 2026 88.72 87.98 to 90.03 -1.08% 0.32 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top